Insider Profile · SEC Form 4 Activity · Trailing 90 Days
Roche John C
Over the trailing 90 days, Roche John C (Other at HANOVER INSURANCE GROUP, INC.) traded $14.8M of stock (net selling $5.1M) in THG, per 16 SEC Form 4 transactions.
- Role
- Other
- Companies
- THG
- Window
- Trailing 90 days · 16 transactions · CIK 1428157
- Net activity
- −$5.1M ($4.8M bought · $10.0M sold)
By Company (Trailing 90 Days)
| Symbol | Company | Txns | Bought | Sold | Net |
|---|---|---|---|---|---|
| THG | HANOVER INSURANCE GROUP, INC. | 16 | $4.8M | $10.0M | −$5.1M |
Transactions (16)
| Date | Symbol | Type | Shares | Value | Description |
|---|---|---|---|---|---|
| 2026-06-26 | THG | Buy | 122 | $0 | Grant, award or other acquisition |
| 2026-05-20 | THG | Sell | 5.1K | $998K | Open market or private sale |
| 2026-05-20 | THG | Sell | 3.2K | $609K | Open market or private sale |
| 2026-05-20 | THG | Sell | 61 | $12K | Open market or private sale |
| 2026-05-19 | THG | Buy | 24.0K | $2.5M | Exercise or conversion of derivative security |
| 2026-05-19 | THG | Sell | 24.8K | $4.8M | Payment of exercise price or tax liability by delivering securities |
| 2026-05-19 | THG | Sell | 9.1K | $0 | Exercise or conversion of derivative security |
| 2026-05-19 | THG | Sell | 24.0K | $0 | Exercise or conversion of derivative security |
| 2026-05-19 | THG | Buy | 9.1K | $781K | Exercise or conversion of derivative security |
| 2026-05-18 | THG | Sell | 100 | $20K | Open market or private sale |
| 2026-05-18 | THG | Sell | 375 | $74K | Open market or private sale |
| 2026-05-18 | THG | Sell | 2.3K | $447K | Open market or private sale |
| 2026-05-18 | THG | Sell | 2.5K | $500K | Open market or private sale |
| 2026-05-15 | THG | Sell | 12.9K | $2.5M | Payment of exercise price or tax liability by delivering securities |
| 2026-05-15 | THG | Buy | 18.2K | $1.6M | Exercise or conversion of derivative security |
| 2026-05-15 | THG | Sell | 18.2K | $0 | Exercise or conversion of derivative security |
Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.
Follow Roche's next move
Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.